Gene Transfer Corrects Acute GM2 Gangliosidosis—Potential Therapeutic Contribution of Perivascular Enzyme Flow
Molecular Therapy2012Vol. 20(8), pp. 1489–1500
Citations Over TimeTop 10% of 2012 papers
María Begoña Cachón-González, Susan Z. Wang, Rosamund McNair, Josephine Bradley, David Lunn, Robin J. Ziegler, Seng H. Cheng, Timothy M. Cox
Related Papers
- → Mice lacking both subunits of lysosomal β–hexosaminidase display gangliosidosis and mucopolysaccharidosis(1996)198 cited
- → Plasma GM2 ganglioside potential biomarker for diagnosis, prognosis and disease monitoring of GM2-Gangliosidosis(2022)11 cited
- → Western blotting analysis of the β-hexosaminidase α- and β-subunits in cultured fibroblasts from cases of various forms of GM2 gangliosidosis(2002)9 cited
- → Detection of GM2-gangliosidosis (Tay-sachs and Sandhoff disease) gene carriers by serum hexosaminidase assay(1976)8 cited
- [Sandhoff's disease (GM2 gangliosidosis, type II). Presentation of a case with a clinical and biochemical study. Carrier detection].(1984)